Physician profile
Paul C Noblitt
NPI 1467114397
$1,083.48
in general payments reported to CMS, 2019-2025
6 companies · $122 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.31 · 2022: $88.11 · 2023: $580 · 2024: $259 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $501.81 | 2021-2025 | |
| Abbott Laboratories | $280.07 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $188.01 | 2023-2024 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.00 | 2022-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $36.81 | 2024-2025 | Assure Wcd |
| Novo Nordisk INC | $17.78 | 2023 | Wegovy, Saxenda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Noblitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.